Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells.

Brown RA, Voit A, Srikanth MP, Thayer JA, Kingsbury TJ, Jacobson MA, Lipinski MM, Feldman RA, Awad O.

Dis Model Mech. 2019 Oct 16;12(10). pii: dmm038596. doi: 10.1242/dmm.038596.

2.

Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition.

Panicker LM, Srikanth MP, Castro-Gomes T, Miller D, Andrews NW, Feldman RA.

Hum Mol Genet. 2018 Mar 1;27(5):811-822. doi: 10.1093/hmg/ddx442.

3.

Altered Differentiation Potential of Gaucher's Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation.

Awad O, Panicker LM, Deranieh RM, Srikanth MP, Brown RA, Voit A, Peesay T, Park TS, Zambidis ET, Feldman RA.

Stem Cell Reports. 2017 Dec 12;9(6):1853-1867. doi: 10.1016/j.stemcr.2017.10.029. Epub 2017 Nov 30.

Supplemental Content

Loading ...
Support Center